Nowhere is patent protection more important than in the pharmaceutical industry. Our pharmaceutical patent practice is second to none, and we have a concentration of pharmaceutical patent expertise envied by our competitors. We represent many of the world's major pharmaceutical companies, including Amgen, Astellas, AstraZeneca, Bausch & Lomb, Bristol-Myers Squibb, Daiichi Sankyo, Genzyme, Kyowa Hakko, Merck, Novartis, Sepracor, Sanofi-Aventis and UCB.

These clients repeatedly entrust us with cases involving their most valuable intellectual property, the patents on blockbuster drugs that are vital to their continued growth. We have been involved in representing branded pharmaceutical companies in defending against generic challengers for more than 20 years and we believe that we have handled more ANDA-based litigations than any other firm. We have advised clients, not only on responding to an ANDA challenge after one is received, but also in preparing well in advance to meet such challenges. We have litigated patents in virtually every field of medicine, including such diverse subjects as anti-infectives, antipsychotics, oncologics, cardiovascular drugs, fertility control, hormone replacement, anti-ulcer drugs, antiinflammatories, anti-epileptics and anti-virals. Our staff of lawyers have experience and training in all aspects of chemistry and pharmaceuticals.

Representative Cases

AstraZeneca Pharms. LP, et al. v. Anchen Pharms, Inc., et al.
U.S. Court of Appeals for the Federal Circuit
Bone Care Int'l v. Roxane Labs. et al.
D. Del. 2012
Otsuka Pharmaceutical Co., Ltd. v. Sandoz, Inc., et al.
Fed. Cir. 2012
AstraZeneca Pharmaceuticals LP et al. v. Anchen Pharmaceuticals Inc. et al.
D.N.J. 2012
Pieczenik v. Bayer Corp., et al.
Fed. Cir. 2012
Genzyme Corporation v. Pentech Pharmaceuticals, Inc. and Cobrek, Inc.
N.D. Ill. 2012
Merck & Co., Inc. and Merck Sharp & Dohme Corp. v. Sandoz Inc.
D.N.J. 2012
Warner Chilcott Laboratories Ireland Limited, et al., v. Mylan Pharmaceuticals Inc. and Mylan Inc.
D.N.J. 2011
Sanofi-Aventis U.S. LLC et al. v. Sun Pharmaceutical Industries Ltd. et al.
D.N.J. 2011
Hoechst GmbH v. Genentech, Inc.
ICC International Court of Arbitration 2011
Daiichi Sankyo Company, Ltd., et al. v. Mylan Pharmaceuticals, Inc. et al.
S. Ct. 2011
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. and Mylan Inc.
D.N.J. 2011
Amgen et al. v. Teva Pharmaceuticals, et al.
D. Del. 2011
Otsuka Pharmaceutical Co., Ltd., v. Sandoz Inc., et al.
D.N.J. 2010
Fitzpatrick Successfully Defends Plavix Patent in Two U.S. Patent Office Reexaminations
U.S. Patent and Trademark Office
Sanofi-Aventis, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership v. Apotex, Inc. & Apotex, Corp.
S.D.N.Y. 2010
Daiichi Sankyo Company, Ltd., et al. v. Mylan Pharmaceuticals, Inc. et al.
Fed. Cir 2010
Adams Respiratory Therapeutics, Inc et al. v. Perrigo Company et al.
Fed Cir. 2010
In re Rosuvastatin Calcium Patent Litigation
D. Del. 2010
Novartis Pharmaceuticals Corporation and Novartis Pharma AG v. Teva Pharmaceuticals USA Inc.
D.N.J. 2009
AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd., v. Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd and Sandoz, Inc.
Fed. Cir. 2009
Sanofi-Aventis U.S. LLC, Sanofi-Aventis, and Debiopharm S.A. v. Sandoz, Inc. et al.
Fed. Cir. 2009
Unigene Labs., Inc., et al. v. Apotex, Inc., et al.
S.D.N.Y., 2009
Daiichi Sankyo Company, Ltd., et al. v. Mylan Pharmaceuticals, Inc. et al.
D.N.J., 2009
Sanofi-Synthelabo, et al. v. Apotex, Inc.
Fed. Cir. 2008
Merck & Co., Inc. v. Apotex Inc., et al.
Fed. Cir. 2008
AstraZeneca Pharmaceutical LP et al. v. Teva Pharmaceuticals USA, Inc, et al.
D.N.J. 2008
Merck & Co., Inc. v. Apotex Inc., et al.
D.N.J. 2007
Sanofi-Synthelabo, et al. v. Apotex Inc.
S.D.N.Y. 2007
Merck & Co, Inc. v. Hi-Tech Pharmacal Co., Inc.
Fed. Cir. 2007
Adams Respiratory Operations, Inc. v. Mutual Pharmaceutical Co., et al.
E.D.Pa. 2007
Astellas Pharma Inc., et al. v. Ranbaxy Inc., et al.
D.N.J. 2007
Sanofi-Synthelabo, Sanofi-Synthelabo Inc. and Bristol-Myers Squibb, sanofi Pharmaceuticals Holding Partnership v. Apotex Inc. and Apotex Corp.
Fed. Cir. and S.D.N.Y 2006
UCB Societe Anonyme & UCB Pharma Inc. v. Mylan Laboratories, Inc. et al.
N.D. GA 2006
Teva Pharmaceuticals USA, Inc. v. Novartis
D.N.J. 2005
Mylan Pharmaceuticals Inc. v. Merck & Co., Inc.
M.D. PA 2005
Eli Lilly and Company, et al. v. Teva Pharmaceuticals USA, Inc.
Fed. Cir. 2005
Pfizer, Inc. and Warner-Lambert Company v. Ranbaxy Pharmaceuticals and Teva Pharmaceuticals
D.N.J. 2005
Eli Lilly and Company, et al. v. Teva Pharmaceuticals USA, Inc.
S.D. Indiana 2004
SmithKline Beecham Corporation v. Teva Pharmaceuticals USA, Inc.
D.N.J. 2004
The Regents of the University of Michigan and Repligen Corp. v. Bristol-Myers Squibb
Fed. Cir. 2004
Warner-Lambert Company v. Teva Pharmaceuticals Inc.
D.N.J. 2004
Novartis Pharmaceuticals Corp. v. Apotex Corp.
S.D.N.Y. 2004
Housey Pharmaceuticals v. Bristol-Myers Squibb Co.
Fed. Cir. 2004
University of Rochester v. G.D. Searle and Co., Inc., Pfizer Inc., Monsanto Co., and Pharmacia Corp.
Fed. Cir. 2004
Warner-Lambert Company v. Teva Pharmaceuticals USA
D.N.J. 2003
The Regents of the University of Michigan and Repligen Corp. v. Bristol-Myers Squibb Co.
E.D. Mich. 2003
AstraZeneca AB, et al. v. Mutual Pharmaceutical Co., Inc.
E.D.Pa 2003
Bristol-Myers Squibb Company v. Rhone-Poulenc Rorer, Inc. et. al.
Fed. Cir. 2003
University of Rochester v. G.D. Searle & Co., Inc., Pfizer Inc., Monsanto Co., and Pharmacia Corp.
W.D.N.Y. 2003
In re Omeprazole Patent Litigation
S.D.N.Y. 2002
Warner-Lambert Co. v. Teva Pharmaceuticals USA
D.N.J. 2002
AstraZeneca AB, et al. v. Mutual Pharmaceutical Co., Inc.
E.D.Pa. 2002
Schwartz Pharma Inc., Schwartz Pharma AG and Warner-Lambert Co. v. Teva Pharmaceuticals USA
D.N.J. 2002
FTAP Holdings, Inc. et.al. V. OWL Pharmaceuticals LLC et.al.
N.D. Ohio 2002
Allergan v. Bausch & Lomb and Alcon
C.D. Cal., 2002
Housey Pharmaceuticals v. Bristol-Myers Squibb Co.
D.Del 2002
Yamanouchi Pharmaceutical Co., Ltd. v. Danbury Pharmacal, Inc.
Fed. Cir. 2000
Bausch & Lomb, Inc. v. Alcon Laboratories, Inc.
W.D.N.Y. 1999
Ben Venue Laboratories v. Novartis Pharmaceuticals Corp.
D.N.J. 1998
Grain Processing Corp. v. American Maize-Products Co.
Fed. Cir. 1998
Ciba-Geigy v. Crompton & Knowles Corp.
E.D. Pa. 1991
Parker Laboratories v. Pharmaceutical Innovations
S.D.N.Y. 1991

PUBLICATIONS

Supreme Court Hears Oral Argument in Myriad Genetics
Fitzpatrick Case Update
April 15, 2013
Supreme Court to Decide Legality of Reverse-Payment Settlements in Paragraph IV Disputes
Financier Worldwide Magazine
March 2013
Hatch-Waxman Act: Overview
Practical Law Company
March 2013
Proving Obviousness? Understanding the Implications of In re Cyclobenzaprine
China Intellectual Property Magazine
December 2012
Isolated DNA Sequence Patents - Safe for Now in the US
Intellectual Asset Management
November/December 2012
CLS Bank v. Alice Corporation and Bancorp Services v. Sun Life: Contrary Outcomes in Latest Federal Circuit Decisions on Patent-Eligibility of Financial Services Inventions
The Banking Law Journal
October 2012
Akamai Technologies v. Limelight Networks and McKesson Technologies v. Epic Systems: Federal Circuit Changes the Law of Active Inducement
Fitzpatrick Case Update
August 31, 2012
Association for Molecular Pathology et al. v. USPTO and Myriad Genetics: The Federal Circuit Again Affirms the Patentability of Isolated Human Genes
Fitzpatrick Case Update
August 2012
New Uncertainty In Subject Matter Eligibility For Biopharma Products
Financier Worldwide Magazine
July 2012
Bancorp Services v. Sun Life: Latest Federal Circuit Case Finding Financial Services Patents Invalid Under 35 U.S.C. § 101
Fitzpatrick Case Update
July 26, 2012
A Cautionary Tale – Recent Trends Show That False Advertising Cases Are Proliferating With the Stakes Higher Than Ever
Fitzpatrick Client Alert
July 23, 2012
Pay-for-delay – Payment Settlements in Paragraph IV Hatch-Waxman Disputes
Financier Worldwide Magazine
April 2012
Supreme Court Holds That the Federal Rules of Evidence Are the Only Evidentiary Restriction in District Court Review of Board of Patent Appeals and Interferences Decisions
Fitzpatrick Case Update
April 18, 2012
Caraco Holds That Statutory Counterclaim To Correct Patent Information Submitted By Branded Drug Makers To FDA Applies To Inaccurate Use Codes For Method-Of-Use Patents
Fitzpatrick Case Update
April 18, 2012
The Supreme Court's Decision in Mayo v. Prometheus: Medical Process is an Unpatentable Law of Nature
Fitzpatrick Case Update
March 20, 2012
Supreme Court Hears Oral Argument in Hyatt v. Kappos
Fitzpatrick Case Update
January 9, 2012
Supreme Court Hears Oral Argument on the Patent Eligibility of a Medical Process
Fitzpatrick Case Update
December 7, 2011
Patent reissue allows inventors to hedge their bets
The National Law Journal
October 2011
IP Monetisation Due Diligence: The Duration of Exclusivity II
Financier Worldwide
October 2011
America Invents Act Webinar: September 27
September 27, 2011
IP due diligence: key areas of analysis in biotech and pharma transactions
Financier Worldwide
September 2011
Third-Party Opposition of Patent Issuance
China Intellectual Property Magazine
August 2011
Startup America: a commercialisation wakeup call for potentially dormant patented technology
Financier Worldwide
July 2011
Innovator versus Generic
European Pharmaceutical Contractor
June 2011
IP Monetisation Due Diligence: The Duration of Exclusivity
Financier Worldwide
April 2011
Establishing an Intellectual Property Program
Intellectual Property & Technology Law Journal
March 2011
A Myriad of Amicus Briefs
Executive Counsel
Major DNA Patent Case Before The Federal Circuit
February/March 2011
Recent legislation impacts development of biologics
Financier Worldwide
November 2010
Describing Written Description: The Implications of Ariad
China IP Magazine
June 2010
Patent Policing
European Pharmaceutical Contractor
March 2010
Federal Circuit Confirms That Written Description and Enablement are Separate Requirements
Fitzpatrick Case Update
March 22, 2010
Bilski: the life sciences angle
Intellectual Asset Management
February 2010
What's Next for Written Description? - The oral argument in Ariad
Fitzpatrick Case Update
December 8, 2009
Extending the 30-Month FDA Stay in an ANDA Litigation
Fitzpatrick Case Update
July 9, 2009
Variations on a Theme: Five Approved Abbreviated Approval Pathways for Biologics
Bloomberg Health Law
April 2009
Significance of Takeda v. Mylan
IP LAW 360
March 6, 2009
Hatch-Waxman Safe Harbor Construed in 'Merck v. Integra'
The New York Law Journal
July 8, 2005
Doctrine of Inherent Anticipation is Clarified
The National Law Journal
December 8, 2003
Enablement in the Spotlight
The National Law Journal
June 16, 2003

EVENTS/PRESENTATION

International Series Program – Best Practices in Patent Law
Federal Circuit Bar Association
Berlin, Germany
November 28, 2012
Advanced Practical Seminar on Protecting IP Rights Overseas
Beijing, China
October 18, 2012
Women’s Initiative Program - Panel Discussion
New York Office
October 11, 2012
Maximizing Pharmaceutical Patent Life Cycles Conference
American Conference Institute
October 9, 2012
11th Annual Forum on Maximizing Pharma Patent Lifecycles
C5
June 20-21, 2012
International Forum on Freedom to Operate
C5
May 9-10, 2012
6th Annual Paragraph IV Disputes
American Conference Institute
April 24, 2012
12th Annual Maximizing Pharmaceutical Patent Life Cycles Conference
American Conference Institute
October 3-5, 2011
America Invents Act Webinar: September 27
America Invents Act Webinar: September 27
September 27, 2011
Women’s Initiative Program - Panel Discussion
New York Office
June 23, 2011
2nd Annual Conference on Biosimilars
American Conference Institute
Fitzpatrick partners Raymond Mandra and Ha Kung Wong spoke at ACI's 2nd Annual Conference on Biosimilars
June 7-8, 2011
Expert Insights on Hatch-Waxman Litigation Strategies for Brand Names and Generics
Paragraph IV Disputes
Dominick Conde spoke at ACI's Paragraph IV Disputes Conference
May 4, 2011
27th Annual Joint Patent Practice Seminar
Joint Patent Practice Continuing Legal Education, Inc.
April 27, 2011
Through the Eyes of One of Ordinary Skill in the Art
27th Annual Joint Patent Practice Seminar
Daiichi Sankyo Co. v. Matrix Laboratories Ltd. (Fed. Cir. 2010)
April 2011
Supplementing PTE Through the Use of Second Generation Patents
American Conference Institute
Raymond Mandra spoke on Patent Term Extensions
January 27, 2011
3rd Annual Pre-Litigation Strategy, Analysis and Preparation for Paragraph IV Disputes
The Center for Business Intelligence
October 18- 19, 2010
Maximizing Pharmaceutical Patent Life Cycles Conference
American Conference Institute
Partner William E. Solander spoke at ACI's Maximizing Pharmaceutical Patent Life Cycles Conference.
October 6-7, 2010
Developments in Pharmaceutical and Biotech Patent Law 2010
Practicing Law Institute
Partner Colleen Tracy spoke at PLI’s Developments in Pharmaceutical and Biotech Patent Law 2010 Conference on September 16, 2010.
September 16, 2010
Assessing Small Molecule IP: Exclusivities & the Hatch-Waxman Act
lawline.com
September 15, 2010
5th Annual Pharmaceutical & Biotech Patent Litigation Strategies Conference
IQPC
Partners Scott K. Reed and Ha Kung Wong to speak at Biotech Conference in London
May 24-26th, 2010
4th Annual Paragraph IV Disputes: Expert Insights on Hatch-Waxman Litigation Strategies for Brand Names and Generics
American Conference Institute
Partner Filko Prugo spoke at the 4th Annual Paragraph IV Disputes Conference on April 27th.
April 27-28, 2010
5th Annual Conference on Corporate Intellectual Property in China
Shanghai, China
April 22-23, 2010
2nd Annual Paragraph IV on Trial Conference
American Conference Institute
November 12-13, 2009
Managing IP Budgets: Selectively Using Outside Counsel and Other Resources to Efficiently Enhance and Enforce IP Portfolios
Corporate IP Institute Intellectual Property Conference
November 3, 2009
5th Annual Developing IP Strategies for Crystalline Forms Conference
IQPC
November 9-11, 2009
Recent Development in Parties' Obligations in a Hatch-Waxman Act Litigation
ACI's 10th Anniversary Maximizing Pharmaceutical Patent Life Cycles
October 7, 2009
Pharmaceutical Patent Protection And Regulation: A Global Perspective
Second Beijing International Pharmaceutical & Chemical Intellectual Property Forum
August 4-7th, 2009
Navigating the Challenges of ANDA Disputes
Law 360
July 28, 2009
2008 PLAVIX Decisions by the U.S. Court of Appeals for the Federal Circuit and the Supreme Court of Canada
NJIPLA Patent Litigation Seminar
March 9, 2009
The Impact of KSR On Pharma/Bio Patent Obviousness
C5 Pharma & Bio Patent Litigation
February 17-18, 2009
Obviousness Under 35 U.S.C. §103 in the United States
IBC's Biotech and Pharmaceutical Patenting Conference
January 27, 2009
Highlighting In-Depth Interference Practices, Patent Life Cycle Management and Litigation Tactics
IQPC's 2nd Annual Patent Strategies for the Pharma, Biotech and Medical Device Industries
July 15-16, 2008
Recent US Case Law Developments Affecting Primary and Secondary Pharma Patents
C5's 7th Annual Pharma Patent Lifecycles Conference
June 27, 2008
Best Practices for Evaluating Your Infringement Risk and Interpreting the Claims
C5's 5th Annual International Freedom to Operate Forum
June 10, 2008
Bioequivalence: What Lawyers Need to Know
American Conference Institute’s FDA Boot Camp: Basic Training for Products Liability and Patent Lawyers
May 30, 2008
Managing the Risks Associated with Injunctions and At-Risk Launches During Litigation and Appeal
American Conference Institute’s 2nd Annual Paragraph IV Disputes: Expert Insights on Hatch-Waxman Litigation Strategies for Brand Names and Generics
May 1, 2008
Key Factors in Long-Term Lawyer-Client Relationships
AIPLA 2008 Mid-Winter Institute
January 24, 2008
8th Annual Maximizing Pharmaceutical Patent Life Cycles Conference
American Conference Institute
October 24, 2007
Resolving Domestic and International IP Disputes Through Arbitration and Mediation
D.C. Bar Intellectual Property Law Section
May 22, 2007
Unlocking IP Value: What Every Corporate Patent Practitioner Should Know
22nd Annual ABA Intellectual Property Law Conference
April 2007
Where Pharmaceutical Science and Patent Law Battle: Polymorphs and the Solid State
D.C. Bar Intellectual Property Law Section
March 20, 2007
Latest Legislative and Judicial Updates Impacting US Pharma Industry
5th Annual Pharmaceutical Patent Life Cycles Conference
January 20, 2006
Hatch-Waxman Update: (I) Declaratory Judgment Actions, and (II) In re Petering
6th Annual Conference Maximizing Pharmaceutical Patent Life Cycles
October 18, 2005
Claim Construction
NYIPLA/Federal Circuit Bar Association Conference
October 14, 2005
Claim Construction of Pharmaceutical Patents
4th Annual Pharmaceutical Patent Life Cycle Conference
April 19, 2005
Best Practices for Litigating Polymorph and Pharmaceutical Patent Cases
3rd Annual Polymorphism & Crystallization Conference
November 15-17, 2004
Exclusivity and FDA Barriers to Market Entry in the U.S.
EuroLegal Conference - 3rd Annual Pharmaceutical Patent Life Cycles
July 5-6th, 2004
Medicare Prescription Drug, Improvement, and Modernization Act of 2003
Law Seminars International program: Running the Race with Biotechnology
May 3-4, 2004
Best Practices in Pharmaceutical Patent Litigation
Polymorphism & Crystallization Forum 2004: Science, Technology & Intellectual Property
April 26, 2004
Changes in Patent Practice Brought About By the Medicare Prescription Drug, Improvement, and Modernization Act of 2003
Law Seminars International Program:Running the Race with Biotechnology
March 8-9, 2004
Invoking a Patent Challenge: Paragraph IV Certifications and Beyond
4th National Maximizing Pharmaceutical Patent Life Cycles Conference
January 27, 2004
Strategies For Licensing Your Way Out of Trouble
American Conference Institute
November 11, 2003
Developments In Patent Law: Written Description and Best Mode
National Forum on Biotechnology and Pharmaceuticals Conference
April 8, 2003
Exclusivity: Who Can Stay and Who Can Play
Legal Strategies for Maximizing Pharmaceutical Patent Life Cycles Conference
April 1, 2003

IN THE NEWS

Fitzpatrick Recognized as First Tier Intellectual Property Firm by Chambers USA Ten Years in a Row
Chambers USA
May 2013
Fitzpatrick Receives 2013 US IP Specialty Firm of the Year Award
Managing Intellectual Property
March 19, 2013
Fitzpatrick partner recognized as ILO Client Choice Winner
International Law Office, Client Choice Guide 2013
February 2013
Fitzpatrick Receives Top 5 Patent Prosecution Ranking for Leading Patent Filers
Managing Intellectual Property
January 29, 2013
Fitzpatrick Recognized as "National Tier 1" and "New York Tier 1" firm by Best Lawyers and U.S. News & World Report
U.S. News & World Report
November 2012
Nicholas M. Cannella inducted into the American College of Trial Lawyers
October 26, 2012
Fitzpatrick Attorney Named Award Winner by Profiles in Diversity Journal
Profiles in Diversity Journal
September/October 2012
Twelve Fitzpatrick Partners Named As Top New York Intellectual Property Litigators
Super Lawyers: New York Metro Edition
September 2012
Nine Fitzpatrick Lawyers Recognized as Best IP Lawyers in America 2013
Best Lawyers in America 2013
August 2012
Novartis Names Fitzpatrick As A Preferred U.S. Intellectual Property Firm
July 16, 2012
Fitzpatrick Recognized as a Leading Life Sciences Intellectual Property Firm
LMG Life Sciences
June 2012
Fitzpatrick, Cella, Harper & Scinto Recognized as a Leading Patent Firm by IAM Patent 1000
IAM Patent 1000
June 2012
Fitzpatrick Attorney Named Among Top 10 Life Sciences Litigators in the US
Managing Intellectual Property
June 2012
Fitzpatrick Recognized as First Tier Intellectual Property Firm by Chambers USA Nine Years in a Row
Chambers USA
June 2012
Fitzpatrick Listed as Tier 1 Bio Life Sciences and Patent Litigation Law Firm
Managing Intellectual Property
May 2012
Fitzpatrick is listed in The Intellectual Property Hot List
The National Law Journal
May 2012
Fitzpatrick listed as a Leading Intellectual Property Firm in Chambers Global 2012
Chambers Global 2012
April 2012
Fitzpatrick listed as a leading Intellectual Property firm
PLC Which Lawyer
April 2012
Fitzpatrick Honored as 2012 Firm of the Year in Pharmaceutical IP Litigation
Managing Intellectual Property
March 27, 2012
Fitzpatrick listed as a leading Life Sciences firm
PLC Which Lawyer
February 2012
Fitzpatrick partner recognized as ILO Client Choice Winner
International Law Office, Client Choice Guide 2012
February 2012
Fitzpatrick Recognized by Six Fortune 500 Companies as their "Go To Law Firm"
Corporate Counsel
January, 2012
Fitzpatrick Honored by The Legal Aid Society
The Legal Aid Society
November, 2011
Nine Fitzpatrick Lawyers Recognized as Best IP Lawyers in America 2012
Best Lawyers in America 2012
November 2011
Fitzpatrick Recognized as a "National Tier 1" and "New York Tier 1" firm by Best Lawyers and U.S. News & World Report
U.S. News & World Report
November 2011
Nine Fitzpatrick Partners Named As Top New York Intellectual Property Litigators in the 2011 issue of Super Lawyers: New York Metro Edition
Super Lawyers: New York Metro Edition
September 2011
Major Patent Law Reform Passes
September 14, 2011
Eight Fitzpatrick Lawyers Listed As Top Patent Prosecutors In Patent Buddy 2011
Patent Buddy
June 2011
Fitzpatrick Listed as a Band 1 Intellectual Property Firm in Chambers USA 2011
Chambers USA
June 2011
Fitzpatrick listed in the International Who's Who of Patent Lawyers 2011
Who's Who Legal
May 2011
Fitzpatrick listed as a Leading Firm in Intellectual Property in Chambers Global 2011
Chambers Global 2011
April 2011
Fitzpatrick Ranked Leading Firm in PLC Which Lawyer 2011
PLC Which Lawyer 2011
March 2011
Fitzpatrick Receives Pro Bono Award from the Legal Aid Society
Legal Aid Society
November 4, 2010
Fitzpatrick Listed in Tier 1 for Intellectual Property
Benchmark: The Definitive Guide to America's Leading Litigation Firms & Attorneys 2011
November 2010
Nine Fitzpatrick Partners Named As Top New York Intellectual Property Litigators in the 2010 issue of Super Lawyers: New York Metro Edition
Super Lawyers: New York Metro Edition
October 2010
Six Fitzpatrick Lawyers Recognized as Best IP Lawyers in America 2011
Best Lawyers in America 2011
October 2010
Fitzpatrick was chosen as a "National Tier 1" and "New York Tier 1" firm in Intellectual Property Law
U.S. News & World Report
October 2010
Fitzpatrick Listed as a Band 1 Intellectual Property Firm in Chambers USA 2010
Chambers USA
June, 2010
Fitzpatrick, Cella, Harper & Scinto Named the 2010 “Best US IP Law Firm”
International Legal Alliance Summit and Awards
June 8, 2010
The New Face of Patent Law
University of Connecticut School of Law Graduate Report
Spring/Summer, 2010
Life Sciences Elite
Intellectual Asset Management Magazine
April 2010
Rising Star: Fitzpatrick Cella's Colleen Tracy
Law 360
March 31, 2010
Fitzpatrick Listed in Tier 1 for Bio Life Sciences
Managing Intellectual Property IP Handbook 2010
February 2010
ACQ Law Awards
ACQ Finance Magazine
November 2009
Fitzpatrick Listed in Tier 1 for Intellectual Property
Benchmark: The Definitive Guide to America's Leading Litigation Firms & Attorneys 2010
November 2009
Seven Fitzpatrick Lawyers Listed as Best IP Lawyers in America 2010
Best Lawyers in America 2010
October 2009
Nine Fitzpatrick Partners Named As Top New York Intellectual Property Litigators in the 2009 issue of Super Lawyers: New York Metro Edition
Super Lawyers: New York Metro Edition
October 2009
Intellectual Property in the Life Sciences Industry
Corporate INTL
October 2009
Fitzpatrick Listed as a Band 1 Intellectual Property Firm in Chambers USA 2009
Chambers USA 2009
June 2009
Fitzpatrick Named as Leading New York Firm
Practical Law Company's Which Lawyer? Yearbook
April 2009
Managing Intellectual Property North American IP Awards
Managing Intellectual Property
March 30, 2009
Fitzpatrick Ranked in Top Five in IP Today's Annual Survey
Intellectual Property Today
March 2009
Eleven Fitzpatrick Lawyers Recognized by Legal Media Group Expert Guides
Guide to the World's Leading Patent Law Practitioners
March 2009
Fitzpatrick Listed as a Tier 1 Intellectual Property Firm in Chambers Global 2009
Chambers Global 2009
January 2009
Seven Fitzpatrick Lawyers Listed as Best IP Lawyers in America 2009
Best Lawyers in America 2009
October 2008
Nine Fitzpatrick Partners Named As Top New York Intellectual Property Litigators in the 2008 issue of Super Lawyers: New York Metro Edition
Super Lawyers: New York Metro Edition 2008
October 2008
Fitzpatrick Named as Leading New York Firm
Practical Law Company's Which Lawyer? Yearbook
2008
Two Fitzpatrick Attorneys Named Best of the Best 2008
Legal Media Guide The Best of the Best U.S. 2008
2008
Pharmaceutical IP Litigation Firm of the Year
Managing Intellectual Property North American IP Awards
April 3, 2008
Fitzpatrick Ranked in Top Five in IP Today's Annual Survey
Intellectual Property Today
March 2008
Fitzpatrick Listed as a Tier 1 Intellectual Property Firm in Chambers Global 2008
Chambers Global 2008
January 2008
Seven Fitzpatrick Lawyers Listed as Best IP Lawyers in America 2008
Best Lawyers in America 2008
October 2007
Nine Fitzpatrick Partners Named As Top New York Intellectual Property Litigators in the 2007 issue of Super Lawyers: New York Metro Edition
Super Lawyers: New York Metro Edition 2007
September 2007
Fitzpatrick Attorneys Featured in New York Magazine Profile
New York Magazine
July 2-9, 2007
Fitzpatrick Named as Leading New York Firm
PLC Which Lawyer Yearbook 2007
May 2007
Fitzpatrick Listed as Tier 1 Intellectual Property Firm in Chambers Global 2007
Chambers Global 2007
January 2007
Fitzpatrick Listed as Top IP Firm with Five Mentions on Who Protects IP America Survey
IP Law & Business
November 2006
Seven Fitzpatrick Lawyers Listed as Best IP Lawyers in America 2007
Best Lawyers in America 2007
October 2006
Two Fitzpatrick Lawyers Named Best of the Best 2006
The US Best of the Best
July 2006
Fitzpatrick Ranked #5 for Initiating Patent Litigation
IP Law & Business
July 2006
Fitzpatrick Named as a Leading Firm in Chambers Global 2006
Chambers Global The World's Leading Lawyers for Business
2006
Fitzpatrick Ranked #7 Most Diverse Law Firm in New York
The New York Law Journal's Book of Lists 2006
March 2006
Fitzpatrick Named as Leading New York Firm
PLC Which Lawyer Yearbook 2006
February 2006
Two New Fitzpatrick Partners Named in 2006
January 1, 2006
Fitzpatrick Ranked Leading Firm in PLC Which Lawyer 2005/2006
PLC Which Lawyer 2005/2006
December 2005
Eight Fitzpatrick Lawyers Listed as Best IP Lawyers in America 2006, The Most Listed for IP in New York
Best Lawyers in America 2006
September 2005
Fitzpatrick Ranked in Band 1 in 2005 Chambers USA Survey
Chambers USA: America's Leading Lawyers for Business
May 25, 2005
Seven Fitzpatrick Lawyers Included on List of Best IP Lawyers in America
Best Lawyers in America
2005-2006
Fitzpatrick Lawyer Selected By Chambers USA As Leader In the Field of Intellectual Property
Chambers USA
February 3, 2005
Fitzpatrick Attorney Named To Top Global Counsel List
Global Counsel 3000; Intellectual Property
2004-2005
Fitzpatrick Receives 2004 MCCA Thomas L. Sager Award
November/December 2004
Fitzpatrick's Pharmaceutical Practice Highlighted in Crain's New York Business Article
Crain's New York Business
September 27, 2004
Fitzpatrick Client, Novartis, Wins Consent Judgment in Lamisil® Litigation
IP Law Bulletin
September 3, 2004
Fitzpatrick Ranked #4 In 2004 Diversity Scorecard
June 2004
Fitzpatrick Ranked as Leading Firm in 2004 Chambers USA Survey
Chambers USA: Leading Business Lawyers
April 21, 2004
Bob Baechtold Named Best of the Best 2004
Euromoney Expert Guide
April 2004
Fitzpatrick Elects Three New Partners
January 1, 2004
Seven Fitzpatrick Lawyers Listed as Best IP Lawyers in America
Best Lawyers in America
2003-2004
Fitzpatrick Ranked As A Top U.S. Intellectual Property Law Firm
Chambers Global: World's Leading Lawyers 2003 and Chambers USA: America's Leading Business Lawyers
2003-2004
Partner Bob Baechtold Ranked a Tier 1 IP Lawyer in New York
Chambers Global: World's Leading Lawyers 2003 and Chambers USA: America's Leading Business Lawyers 2003-2004
2003-2004
Fitzpatrick Associate Featured in NYLJ Article
New York Law Journal
December 12, 2003
Fitzpatrick Ranked # 10 In 2002 Diversity Scorecard
December 2003
Fitzpatrick's Pharmaceutical Practice Highlighted in IP Law & Business Article
November 2003
Partner Leisa M. Smith Receives The Network Journal's 40-Under Forty Achievement Award
June 19, 2003
Fitzpatrick Announces Two New Partners
January 1, 2003
Six Fitzpatrick Lawyers Ranked as World's Leading Patent Experts
2003 Guide to the World's Leading Patent Law Experts
2003
Three New Fitzpatrick Partners Named 2002
January 2002
Fitzpatrick Receives 2002 MCCA Thomas L. Sager Award
October 16, 2002
Robert L. Baechtold Voted Best of the Best 2002
Best of the Best
2002
Fitzpatrick, Cella Recognized for 20 Years of Service to Improving Justice
December 13, 2001
California Office Relocates to Larger Quarters
2001
Charles P. Baker Elected as Chair of the American Bar Association's Intellectual Property Law Section
2001
Four Partners Nominated to the International Who's Who of Business Lawyers
2001
Robert L. Baechtold Elected President-elect of the Federal Circuit Bar Association
2001
Bob Baechtold Named "THE BEST OF THE BEST 2000"
2000

PRESS RELEASES

New Partners Named
January 15, 2013
Fitzpatrick, Cella, Harper & Scinto Recognized for the Seventh Time as a Burton Award Recipient
June 16, 2011
Fitzpatrick, Cella, Harper & Scinto Recognized as Intellectual Property Leader by Chambers USA Eight Years in a Row
Chambers & Partners USA 2011
June 14, 2011
New Partners Named
January 5, 2011
Fitzpatrick, Cella, Harper & Scinto Honored For Industry Excellence in Intellectual Property by Chambers & Partners
Chambers & Partners USA 2010
June 14, 2010
Best US IP Law Firm
International Legal Alliance Summit and Awards 2010
June 2010
Life Science/Biotech & Pharmaceutical IP Litigation Firm of the Year
April 2010
Fitzpatrick, Cella, Harper & Scinto Elects Jason M. Okun as New Partner
January 4, 2010
Fitzpatrick, Cella, Harper, & Scinto Named “Decade Award Winner” in Legal Writing by the Burton Foundation
Burton Foundation
December 16, 2009
Fitzpatrick, Cella Listed as a Tier One Intellectual Property Firm
Institutional Investor's 2010 Benchmark Litigation Guide
December 2009
Fitzpatrick named Patent Law Firm of the Year: North America
ACQ Finance Magazine
December 01, 2009
Fitzpatrick, Cella, Harper & Scinto's New York Headquarters Relocates
September 2009
Fitzpatrick Successfully Defends Blockbuster Drug Benicar®
August 7, 2009
Fitzpatrick, Cella, Harper & Scinto Honored by Chambers & Partners in Tier 1 for New York Intellectual Property Law Firms
Chambers & Partners USA 2009
June 16, 2009
Firm to be Recognized As a Burton Award Recipient For the Fifth Time
2009 Burton Awards
April 14, 2009
Pharmaceutical IP Litigation Firm of the Year
Managing Intellectual Property
March 30, 2009
Colleen Tracy named Managing Partner at Fitzpatrick, Cella, Harper & Scinto
Health Law & Intellectual Property Law Highlights
March 2009
Colleen Tracy Named as Fitzpatrick's Managing Partner
March 19, 2009
New Partners Named
January 6, 2009
Fitzpatrick, Cella, Harper & Scinto Ranked #1 in Intellectual Property
Chambers USA 2008
June 16, 2008
Fitzpatrick, Cella, Harper & Scinto Receives 2008 Burton Legal Achievement Award
May 12, 2008
New Partners named in January 2008
January 2, 2008
Fitzpatrick Prevails in Patent Infringement Suit
Fitzpatrick Wins Patent Infringement Suit on Behalf of Bristol-Myers and Sanofi Against Apotex over Generic Plavix
June 21, 2007
Fitzpatrick, Cella, Harper & Scinto Ranked #1 in Intellectual Property
June 2007
Fitzpatrick Cella Announces Win in Trusopt® Patent-Infringement Case
Fitzpatrick Cella Wins Appeal on behalf of Merck & Co. in Trusopt® Patent-Infringement Case
April 2007
Fitzpatrick Cella Elects Five New Partners
January 1, 2007
Fitzpatrick, Cella, Harper & Scinto Ranked #1 in IP
Fitzpatrick, Cella, Harper & Scinto Ranked #1 in Intellectual Property in Chambers & Partners’ 2006 U.S. Guide
June 2006
Fitzpatrick Commences Legal Action on Behalf of Clients Eisai Co. and Eisai Inc. Over Aricept ANDA Filing
December 2005
Fitzpatrick Commences Legal Action on Behalf of Client AstraZeneca Over Seroquel Patent
November 14, 2005
Fitzpatrick, Cella, Harper & Scinto Receives Minority Corporate Counsel Association's Thomas L. Sager Diversity Award
October 2004
Fitzpatrick Commences Legal Action on Behalf of Clients Wyeth and Altana Pharma Over Protonix ANDA Filing
Fitzpatrick Commences Legal Action on Behalf of Clients Wyeth and Altana Pharma Over Protonix ANDA Filing
May 2004
Fitzpatrick Elects Three Partners
January 5, 2004
Fitzpatrick, Cella Commences Legal Action on Behalf of Client Eisai Over Aciphex ANDA Filings
December 2003
John D. Murnane Joins Fitzpatrick's Patent Practice
June 2, 2003
Fitzpatrick Elects Two Partners
January 6, 2003
Fitzpatrick Receives Thomas L. Sager Diversity Award
October 2002

Area Leader/Chair:Dominick A. Conde

ATTORNEYS IN THIS PRACTICE AREA

PartnersChristopher P. Borello
Tara A. Byrne
Nicholas M. Cannella
John D. Carlin
Dominick A. Conde
Donald J. Curry
Daniel S. Glueck
Bruce C. Haas
Edmund J. Haughey
Elizabeth F. Holowacz
Nicholas N. Kallas, Ph.D.
Timothy J. Kelly
Steven C. Kline
Christopher E. Loh
Leisa Smith Lundy
Raymond R. Mandra
Michael P. McGraw
John D. Murnane
Jason M. Okun
Lisa Barons Pensabene
Marc J. Pensabene
Lawrence S. Perry
Filko Prugo
Scott K. Reed
Henry J. Renk
Joshua I. Rothman
Alicia A. Russo
Diego Scambia
Robert S. Schwartz, Ph.D.
Gregory B. Sephton, Ph.D.
Brian V. Slater
William E. Solander
Stephen K. Sullivan, Ph.D.
Colleen Tracy
Ha Kung Wong

Of CounselRobert L. Baechtold

CounselJessica Hiney

AssociatesCassandra A. Adams
Dennis C. Aeling
Erin J.D. Austin
Will C. Autz
Alice Braginsky
April M. Breyer
Megan A. Chacon
Patrick L. Chen
Siew Yen Chong, Ph.D.
Jeffrey R. Colin
M. Diana Danca, Ph.D.
Fiona E. Darkin
Joshua A. Davis
John P. Dillon
Dominick P. DiSabatino
Damien N. Dombrowski
Susanne L. Flanders
Michael Enzo Furrow, Ph.D.
Kimberley A. Gavin, Ph.D.
Melissa Gibson
C. Austin Ginnings
Joanna Garelick Goldstein
Dennis Gregory
Vishal C. Gupta
Margaret A. Hallet
Lindsay H. Hersh
Caitlin P. Hogan
Anna Huang
Cheney H. Huang
Charlotte Jacobsen
Allyson King
John W. Kirkland
Marissa T. Kovary
Leslie Kushner, Ph.D.
Andrew Kutas
Adam C. LaRock
Dana Lau, Ph.D.
Jason A. Leonard
Kristina M. Mahoney
Leila Kaplus Marcovici
Gabrielle Markeson
Scott A. McMurry Ph.D.
Whitney L. Meier
Frederick C. Millett
Dillon J. Murphy
Erica L. Norey
Daniel O'Boyle
Jason E. O'Leary
Brendan M. O'Malley, Ph.D.
Enes Ovcina
Jessica J. Pai
Joseph P. Pieroni, Ph.D.
Robert W. Pierson Jr.
Galen E. Rahmlow
Christina Schwarz
Margaret A. Scoolidge
Shannon K. Stevens
Jared L. Stringham
James Tyminski
Damond E. Vadnais
Sujatha Vathyam, Ph.D.
Chandrika Vira
Carolyn S. Wall
Yuanheng “Sally” Wang
Lori A. Wolfe
Lauren B. Zuffante